Studies on antidiabetic agents. IV. Synthesis and activity of the metabolites of 5-(4-(1-methylcyclohexylmethoxy)benzyl)-2,4-thiazolidinedione (ciglitazone).
- 1 January 1984
- journal article
- research article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 32 (6) , 2267-2278
- https://doi.org/10.1248/cpb.32.2267
Abstract
Compounds possessing a hydroxy or an oxo moiety on the cyclohexane ring of 5-[4-(1-methylcyclohexylmethoxy)benzyl]-2,4-thiazolidinedione (1, ciglitazone) were synthesized to clarify the structure of the metabolites of 1 and for studies of their pharmacological properties. Of the metabolites identified, 5-[4-(t-3-hydroxy-1-methyl-r-1-cyclohexylmethoxy)benzyl]-2,4-thiazolidinedione (7) exhibited extremely potent antidiabetic activity [in mice] compared to 1. Stereoselective syntheses of 3- or 4-hydroxy-1-methylcyclohexanecarboxylic acids required for the preparation of 3''- or 4''-hydroxylated compounds are described.This publication has 2 references indexed in Scilit:
- Studies on antidiabetic agents. III. 5-Arylthiazolidine-2,4-diones as potent aldose reductase inhibitors.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- Studies on antidiabetic agents. II. Synthesis of 5-(4-(1-methylcyclohexylmethoxy)-benzyl)thiazolidine-2,4-dione (ADD-3878) and its derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982